Literature DB >> 10233916

The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis.

M Makino1, S Shimokubo, S I Wakamatsu, S Izumo, M Baba.   

Abstract

The development of human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is closely associated with the activation of T cells which are HTLV-1 specific but may cross-react with neural antigens (Ags). Immature dendritic cells (DCs), differentiated from normal donor monocytes by using recombinant granulocyte-macrophage colony-stimulating factor and recombinant interleukin-4, were pulsed with HTLV-1 in vitro. The pulsed DCs contained HTLV-1 proviral DNA and expressed HTLV-1 Gag Ag on their surface 6 days after infection. The DCs matured by lipopolysaccharides stimulated autologous CD4(+) T cells and CD8(+) T cells in a viral dose-dependent manner. However, the proliferation level of CD4(+) T cells was five- to sixfold higher than that of CD8(+) T cells. In contrast to virus-infected DCs, DCs pulsed with heat-inactivated virions activated only CD4(+) T cells. To clarify the role of DCs in HAM/TSP development, monocytes from patients were cultured for 4 days in the presence of the cytokines. The expression of CD86 Ag on DCs was higher and that of CD1a Ag was more down-regulated than in DCs generated from normal monocytes. DCs from two of five patients expressed HTLV-1 Gag Ag. Furthermore, both CD4(+) and CD8(+) T cells from the patients were greatly stimulated by contact with autologous DCs pulsed with inactivated viral Ag as well as HTLV-1-infected DCs. These results suggest that DCs are susceptible to HTLV-1 infection and that their cognate interaction with T cells may contribute to the development of HAM/TSP.

Entities:  

Mesh:

Year:  1999        PMID: 10233916      PMCID: PMC112498     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  M Makino; M Azuma; S I Wakamatsu; Y Suruga; S Izumo; M M Yokoyama; M Baba
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma.

Authors:  K Usuku; S Sonoda; M Osame; S Yashiki; K Takahashi; M Matsumoto; T Sawada; K Tsuji; M Tara; A Igata
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection.

Authors:  P Höllsberg; D A Hafler
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245

5.  Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy.

Authors:  R Kubota; T Fujiyoshi; S Izumo; S Yashiki; I Maruyama; M Osame; S Sonoda
Journal:  J Neuroimmunol       Date:  1993-02       Impact factor: 3.478

6.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

7.  Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.

Authors:  P U Cameron; P S Freudenthal; J M Barker; S Gezelter; K Inaba; R M Steinman
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

8.  Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation.

Authors:  S E Macatonia; J K Cruickshank; P Rudge; S C Knight
Journal:  AIDS Res Hum Retroviruses       Date:  1992-09       Impact factor: 2.205

Review 9.  Interactions of viruses with dendritic cells: a double-edged sword.

Authors:  N Bhardwaj
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells.

Authors:  I Fugier-Vivier; C Servet-Delprat; P Rivailler; M C Rissoan; Y J Liu; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  37 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

2.  DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells.

Authors:  Pierre-Emmanuel Ceccaldi; Frédéric Delebecque; Marie-Christine Prevost; Arnaud Moris; Jean-Pierre Abastado; Antoine Gessain; Olivier Schwartz; Simona Ozden
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  A novel high throughput quantum dot-based fluorescence assay for quantitation of virus binding and attachment.

Authors:  Karan Kampani; Kevin Quann; Jaya Ahuja; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Virol Methods       Date:  2007-01-03       Impact factor: 2.014

4.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

5.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

6.  Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.

Authors:  Rita Elizabeth Mascarenhas; Cláudia Brodskyn; Geisa Barbosa; Jorge Clarêncio; Antônio Souza Andrade-Filho; Frederico Figueiroa; Bernardo Galvão-Castro; Fernanda Grassi
Journal:  Clin Vaccine Immunol       Date:  2006-05

7.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.

Authors:  Saifur Rahman; Sharrón L Manuel; Zafar K Khan; Brian Wigdahl; Edward Acheampong; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

Review 8.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

9.  Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae.

Authors:  Masahiko Makino; Yumi Maeda; Katsuya Inagaki
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

10.  DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.

Authors:  Pooja Jain; Sharrón L Manuel; Zafar K Khan; Jaya Ahuja; Kevin Quann; Brian Wigdahl
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.